RXSIGHT INC (RXST) competitors & alternatives
Health Care · NASDAQ
RXSIGHT INC (RXST)'s top competitors and alternatives — its most similar public companies — include Johnson & Johnson (JNJ), STAAR SURGICAL (STAA), Cooper Companies (The) (COO), SPYGLASS PHARMA INC SHS (SGP), GLAUKOS CORP (GKOS), TREACE MEDICAL CONCEPTS, INC. (TMCI), WARBY PARKER INC CLASS A (WRBY), NATIONAL VISION HOLDINGS INC (EYE), ATRICURE INC (ATRC), HINGE HEALTH INC CLASS A (HNGE), OCULAR THERAPEUTIX INC (OCUL) and SS Innovations International, Inc. (SSII). These are RXSIGHT INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top RXST competitors & alternatives
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$255.63 (as of 2026-07-22) · market cap $614.6B
-
STAAR SURGICALSTAAHealth Care
STAAR Surgical designs and manufactures implantable collamer lenses (ICLs) for refractive vision correction, offering reversible alternatives to corneal…
$24.71 (as of 2026-07-22) · market cap $1.2B
-
Cooper Companies (The)COOHealth Care
A global medical device leader operating at the intersection of vision care and women's health through its CooperVision and CooperSurgical divisions.
$70.50 (as of 2026-07-22) · market cap $13.9B
-
SPYGLASS PHARMA INC SHSSGPHealth Care
Spyglass Pharma is a clinical-stage biotech developing an innovative sustained-release drug delivery platform to improve patient outcomes in cataract surgery.
$20.54 (as of 2026-07-22) · market cap $682M
-
GLAUKOS CORPGKOSHealth Care
Glaukos is a specialized ophthalmic company transforming eye care through innovative Micro-Invasive Glaucoma Surgery devices and proprietary sustained-release…
$152.86 (as of 2026-07-22) · market cap $8.9B
-
TREACE MEDICAL CONCEPTS, INC.TMCIHealth Care
Treace is a focused orthopedic medical device company specializing in innovative 3D bunion correction and foot surgery systems for hospitals and surgical…
$3.97 (as of 2026-07-22) · market cap $258M
-
WARBY PARKER INC CLASS AWRBYConsumer Discretionary
A mission-driven, direct-to-consumer eyewear and eye care brand that combines designer-quality glasses, telehealth vision services, and retail stores to make…
$24.55 (as of 2026-07-22) · market cap $3.2B
-
NATIONAL VISION HOLDINGS INCEYEConsumer Discretionary
National Vision is the largest value-focused optical retailer in the U.S., operating 1,250 stores and integrating remote telehealth eye care to serve…
$19.82 (as of 2026-07-22) · market cap $1.6B
-
ATRICURE INCATRCHealth Care
AtriCure is a leading surgical device company treating atrial fibrillation and post-operative pain through minimally invasive cardiac ablation and cryotherapy…
$33.52 (as of 2026-07-22) · market cap $1.7B
-
HINGE HEALTH INC CLASS AHNGEHealth Care
Hinge Health is an AI-driven digital MSK care platform that automates personalized pain treatment and physical therapy through motion-tracking technology and…
$79.08 (as of 2026-07-22) · market cap $6.5B
-
OCULAR THERAPEUTIX INCOCULHealth Care
Ocular Therapeutix is a biopharmaceutical company leveraging proprietary bioresorbable hydrogel technology to deliver retinal therapies, with AXPAXLI…
$8.59 (as of 2026-07-22) · market cap $2.0B
-
SS Innovations International, Inc.SSIIHealth Care
SS Innovations International is a medical technology company specializing in the development and manufacture of robotic-assisted surgical systems.
$3.58 (as of 2026-07-22) · market cap $716M
Not quite? Describe exactly what you want →
Peers are RXSIGHT INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: RXSIGHT INC (RXST).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.